Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity
- PMID: 8233604
Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity
Abstract
We have established a study site in a malaria endemic region around Kataragama in the south of Sri Lanka. A population of about 3,000 individuals in a group of villages around Kataragama have been provided with access to a small field clinic enabling us to monitor aspects of malarial infection under conditions of natural transmission. At the present time, both Plasmodium falciparum and Plasmodium vivax are prevalent to a similar degree although prior to about five years ago P. falciparum had been virtually absent for most of the previous ten years.
Similar articles
-
Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.Int J Parasitol. 2007 Feb;37(2):199-208. doi: 10.1016/j.ijpara.2006.09.002. Epub 2006 Sep 28. Int J Parasitol. 2007. PMID: 17055511
-
Immune responses against sexual stages of Plasmodium vivax during human malarial infections in Sri Lanka.Parassitologia. 1991 Apr;33(1):67-70. Parassitologia. 1991. PMID: 1688139
-
Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.Infect Immun. 2006 Jan;74(1):798-801. doi: 10.1128/IAI.74.1.798-801.2006. Infect Immun. 2006. PMID: 16369044 Free PMC article.
-
Overview: immunology of malaria and progress in malaria vaccine development.Southeast Asian J Trop Med Public Health. 1992 Sep;23 Suppl 4:71-87. Southeast Asian J Trop Med Public Health. 1992. PMID: 1364871 Review. No abstract available.
-
An update on the search for a Plasmodium vivax vaccine.Trends Parasitol. 2007 Mar;23(3):122-8. doi: 10.1016/j.pt.2007.01.008. Epub 2007 Jan 29. Trends Parasitol. 2007. PMID: 17258937 Review.